Free Trial
NASDAQ:MIRA

MIRA Pharmaceuticals (MIRA) Stock Price, News & Analysis

MIRA Pharmaceuticals logo
$0.80 -0.03 (-4.12%)
As of 01:07 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About MIRA Pharmaceuticals Stock (NASDAQ:MIRA)

Key Stats

Today's Range
$0.73
$0.84
50-Day Range
$0.83
$1.28
52-Week Range
$0.51
$5.01
Volume
226,901 shs
Average Volume
1.92 million shs
Market Capitalization
$13.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00
Consensus Rating
Buy

Company Overview

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Miami, Florida.

Remove Ads

MIRA Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
35th Percentile Overall Score

MIRA MarketRank™: 

MIRA Pharmaceuticals scored higher than 35% of companies evaluated by MarketBeat, and ranked 681st out of 901 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MIRA Pharmaceuticals has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MIRA Pharmaceuticals has received no research coverage in the past 90 days.

  • Read more about MIRA Pharmaceuticals' stock forecast and price target.
  • Earnings Growth

    Earnings for MIRA Pharmaceuticals are expected to grow in the coming year, from ($0.60) to ($0.54) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MIRA Pharmaceuticals is -1.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MIRA Pharmaceuticals is -1.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MIRA Pharmaceuticals has a P/B Ratio of 2.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about MIRA Pharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    7.97% of the float of MIRA Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    MIRA Pharmaceuticals has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MIRA Pharmaceuticals has recently increased by 38.88%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    MIRA Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    MIRA Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.97% of the float of MIRA Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    MIRA Pharmaceuticals has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MIRA Pharmaceuticals has recently increased by 38.88%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    MIRA Pharmaceuticals has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.64 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for MIRA Pharmaceuticals this week, compared to 1 article on an average week.
  • Search Interest

    Only 2 people have searched for MIRA on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added MIRA Pharmaceuticals to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MIRA Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.65% of the stock of MIRA Pharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    Only 35.16% of the stock of MIRA Pharmaceuticals is held by institutions.

  • Read more about MIRA Pharmaceuticals' insider trading history.
Receive MIRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

MIRA Stock News Headlines

What is Zacks Small Cap's Estimate for MIRA FY2026 Earnings?
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
MIRA Pharmaceuticals in binding LOI to acquire SKNY Pharmaceuticals
See More Headlines

MIRA Stock Analysis - Frequently Asked Questions

MIRA Pharmaceuticals' stock was trading at $1.14 on January 1st, 2025. Since then, MIRA shares have decreased by 29.8% and is now trading at $0.80.
View the best growth stocks for 2025 here
.

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) posted its quarterly earnings results on Friday, March, 28th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.14.

MIRA Pharmaceuticals (MIRA) raised $9 million in an IPO on Thursday, August 3rd 2023. The company issued 1,275,000 shares at $7.00 per share.

Shares of MIRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MIRA Pharmaceuticals investors own include Plug Power (PLUG), Workhorse Group (WKHS), FuelCell Energy (FCEL), Fortress Biotech (FBIO), Ovid Therapeutics (OVID), Alamos Gold (AGI) and GeoVax Labs (GOVX).

Company Calendar

Last Earnings
3/28/2025
Today
4/07/2025
Next Earnings (Estimated)
4/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MIRA
Previous Symbol
NASDAQ:MIRA
Fax
N/A
Employees
2
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$14.00
High Stock Price Target
$17.00
Low Stock Price Target
$11.00
Potential Upside/Downside
+1,645.6%
Consensus Rating
Buy
Rating Score (0-4)
3.33
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-11,980,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.30 per share
Price / Book
2.67

Miscellaneous

Free Float
15,460,000
Market Cap
$13.48 million
Optionable
Not Optionable
Beta
2.05
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:MIRA) was last updated on 4/7/2025 by MarketBeat.com Staff
From Our Partners